title: Should continuous infusion of beta-lactam antibiotics be the first-line approach?
authors.affiliation: Colegio Universitario de Farmacia, Fundación San Pablo CEU, University of Valencia, Moncada, Spain.
authors.forename: C L
authors.initials: CL
authors.lastname: Ronchera-Oms
authors.forename: S
authors.initials: S
authors.lastname: Gregorio
authors.forename: N
authors.initials: N
authors.lastname: Sanllehí
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016503:Drug Delivery Systems; D016983:Enterococcus / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000254:growth & development; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D008826:Microbial Sensitivity Tests; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D047090:beta-Lactams
chemical_list: D000900:Anti-Bacterial Agents; D047090:beta-Lactams